Michael Tally

2.5k total citations · 1 hit paper
50 papers, 2.0k citations indexed

About

Michael Tally is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Michael Tally has authored 50 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 25 papers in Endocrinology, Diabetes and Metabolism and 19 papers in Surgery. Recurrent topics in Michael Tally's work include Growth Hormone and Insulin-like Growth Factors (23 papers), Metabolism, Diabetes, and Cancer (19 papers) and Pancreatic function and diabetes (19 papers). Michael Tally is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (23 papers), Metabolism, Diabetes, and Cancer (19 papers) and Pancreatic function and diabetes (19 papers). Michael Tally collaborates with scholars based in Sweden, United States and United Kingdom. Michael Tally's co-authors include Kerstin Hall, Anne-Sophie Van Laere, Leif Andersson, Carine Nezer, Alan Archibald, Nadine Buys, Martin Braunschweig, Laurence Moreau, Minh Quang Nguyen and Chris Haley and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michael Tally

50 papers receiving 1.9k citations

Hit Papers

A regulatory mutation in IGF2 causes a major QTL effect o... 2003 2026 2010 2018 2003 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig
    2003 744 citations Michael Tally et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Tally Sweden 20 1.0k 879 520 303 269 50 2.0k
Bruce Kelder United States 24 780 0.8× 261 0.3× 623 1.2× 159 0.5× 340 1.3× 51 2.0k
Irwin L. Flink United States 21 1.0k 1.0× 210 0.2× 365 0.7× 102 0.3× 98 0.4× 31 1.6k
François Boudreau Canada 30 1.5k 1.5× 833 0.9× 157 0.3× 673 2.2× 188 0.7× 90 2.8k
Sandrina Kinet France 26 877 0.9× 321 0.4× 302 0.6× 96 0.3× 243 0.9× 41 2.4k
Roger Powell United States 24 722 0.7× 1.2k 1.4× 470 0.9× 512 1.7× 117 0.4× 38 2.2k
Beverly S. Chilton United States 20 872 0.9× 212 0.2× 138 0.3× 75 0.2× 223 0.8× 60 1.9k
Dennis W. Wolff United States 23 1.2k 1.2× 639 0.7× 62 0.1× 79 0.3× 182 0.7× 39 2.4k
Sanna Lehtonen Finland 26 1.1k 1.1× 333 0.4× 100 0.2× 322 1.1× 171 0.6× 73 1.9k
Fioretta Palombi Italy 26 843 0.8× 235 0.3× 202 0.4× 220 0.7× 126 0.5× 52 2.2k
Aurelian Radu United States 18 1.2k 1.2× 221 0.3× 174 0.3× 151 0.5× 122 0.5× 33 1.9k

Countries citing papers authored by Michael Tally

Since Specialization
Citations

This map shows the geographic impact of Michael Tally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Tally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Tally more than expected).

Fields of papers citing papers by Michael Tally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Tally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Tally. The network helps show where Michael Tally may publish in the future.

Co-authorship network of co-authors of Michael Tally

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Tally. A scholar is included among the top collaborators of Michael Tally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Tally. Michael Tally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellis, Ewa, et al.. (2002). GH is a regulator of IGF2 promoter-specific transcription in human liver. Journal of Endocrinology. 172(3). 457–465. 26 indexed citations
2.
Pramanik, Aladdin, Jawed Shafqat, Zhihui Zhong, et al.. (2001). Specific Binding of Proinsulin C-Peptide to Intact and to Detergent-Solubilized Human Skin Fibroblasts. Biochemical and Biophysical Research Communications. 280(2). 423–427. 31 indexed citations
3.
Pramanik, Aladdin, Karin Ekberg, Zhihui Zhong, et al.. (2001). C-Peptide Binding to Human Cell Membranes: Importance of Glu27. Biochemical and Biophysical Research Communications. 284(1). 94–98. 50 indexed citations
4.
Sjöholm, Åke, Qimin Zhang, Nils Welsh, et al.. (2000). Rapid Ca2+ Influx and Diacylglycerol Synthesis in Growth Hormone-mediated Islet β-Cell Mitogenesis. Journal of Biological Chemistry. 275(28). 21033–21040. 26 indexed citations
5.
Gray, Steven G., et al.. (1999). IGF-II Enhances Trichostatin A-Induced TGFβ1 and p21Waf1,Cip1,Sdi1 Expression in Hep3B Cells. Experimental Cell Research. 253(2). 618–628. 36 indexed citations
6.
7.
8.
Zhang, Qimin, Per‐Olof Berggren, & Michael Tally. (1997). Glucose Increases Both the Plasma Membrane Number and Phosphorylation of Insulin-like Growth Factor II/Mannose 6-Phosphate Receptors. Journal of Biological Chemistry. 272(38). 23703–23706. 18 indexed citations
9.
Helle, Svein Inge, et al.. (1996). Influence of treatment with tamoxifen and change in tumor burden on the IGF‐system in breast cancer patients. International Journal of Cancer. 69(4). 335–339. 1 indexed citations
10.
Helle, Svein Inge, Gun Anker, Michael Tally, Kerstin Hall, & Per Eystein Lønning. (1996). Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients. The Journal of Steroid Biochemistry and Molecular Biology. 57(3-4). 167–171. 23 indexed citations
11.
Helle, Svein Inge, et al.. (1996). Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients. International Journal of Cancer. 69(4). 335–339. 46 indexed citations
12.
Höög, Anders, Ann-Christin Sandberg-Nordqvist, Samy M. Abdel‐Halim, et al.. (1996). Increased amounts of a high molecular weight insulin-like growth factor II (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of diabetic Goto-Kakizaki rats.. Endocrinology. 137(6). 2415–2423. 19 indexed citations
13.
Zierath, Juleen R., Aase Handberg, Michael Tally, & Harriet Wallberg‐Henriksson. (1996). C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia. 39(3). 306–313. 68 indexed citations
14.
Hall, Kerstin, et al.. (1996). Partial purification of an IGF-II receptor/binding protein from the erythroleukemia cell line K562. Molecular and Cellular Biochemistry. 154(1). 47–54. 4 indexed citations
15.
Lønning, Per Eystein, Dag Clement Johannessen, Herman Adlercreutz, et al.. (1995). Relations between sex hormones, sex hormone binding globulin, insulin‐like growth factor‐I and insulin‐like growth factor binding protein‐I in post‐menopausal breast cancer patients. Clinical Endocrinology. 42(1). 23–30. 65 indexed citations
16.
Wadensten, Henrik, Erik Holmgren, Christina Kalderén, et al.. (1991). Purification and characterization of recombinant human insulin‐like growth factor II (IGF‐II) expressed as a secreted fusion protein in Escherichia coli. Biotechnology and Applied Biochemistry. 13(3). 412–421. 9 indexed citations
17.
Spadoni, Gian Luigi, et al.. (1990). Determination of IGF-II levels in human serum using the erythroleukemia cell line K562. Journal of Endocrinological Investigation. 13(2). 97–102. 1 indexed citations
18.
Hall, K. & Michael Tally. (1989). The somatomedin‐insulin‐like growth factors. Journal of Internal Medicine. 225(1). 47–54. 19 indexed citations
19.
Tally, Michael, et al.. (1987). The specificity of the human IGF-2 receptor. Biochemical and Biophysical Research Communications. 147(3). 1206–1212. 20 indexed citations
20.
Tally, Michael, et al.. (1987). IGF-2 stimulated growth mediated by the somatomedin type 2 receptor. Biochemical and Biophysical Research Communications. 148(2). 811–816. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce Kelder Breakdown of academic impact, for papers by Irwin L. Flink Breakdown of academic impact, for papers by François Boudreau Breakdown of academic impact, for papers by Sandrina Kinet Breakdown of academic impact, for papers by Roger Powell Breakdown of academic impact, for papers by Beverly S. Chilton Breakdown of academic impact, for papers by Dennis W. Wolff Breakdown of academic impact, for papers by Sanna Lehtonen Breakdown of academic impact, for papers by Fioretta Palombi Breakdown of academic impact, for papers by Aurelian Radu
Rankless by CCL
2026